Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell-specific liposomal siRNA delivery system.
Maishi N, Sakurai Y, Hatakeyama H, Umeyama Y, Nakamura T, Endo R, Alam MT, Li C, Annan DA, Kikuchi H, Morimoto H, Morimoto M, Akiyama K, Ohga N, Hida Y, Harashima H, Hida K.
Maishi N, et al. Among authors: alam mt.
Cancer Sci. 2022 May;113(5):1855-1867. doi: 10.1111/cas.15323. Epub 2022 Mar 21.
Cancer Sci. 2022.
PMID: 35266253
Free PMC article.